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Purpose: We have evaluated the progression of isolated superficial venous thrombosis to 
deep vein thrombosis in patients with no initial deep venous involvement. 
Methods: Patients with thrombosis olated to the superficial veins with no evidence of deep 
venous involvement by duplex ultrasound examination were evaluated by follow-up 
duplex ultrasonography to determine the incidence of disease progression i to the deep 
veins of the lower extremities. Initial and follow-up duplex scans evaluated the femo- 
ropopliteal and deep calf veins in their entirety; follow-up studies were done at an average 
of 6.3 days, ranging from 2 to 10 days. 
Results: From January 1992 to January 1996, 263 patients were identified with isolated 
superficial venous thrombosis. Thirty (11%) patients had documented progression to deep 
venous involvement. The most common site of deep vein involvement was progression of 
disease from the greater saphenous vein in the thigh into the common femoral vein (21 
patients, 70%), with 18 of these extensions noted to be nonocdusive and 12 having a 
free-floating component. Three patients had extended above-knee saphenous vein thrombi 
through thigh perforators to occlude the femoral vein in the thigh, three patients had 
extended below-knee saphenous disease into the popliteal vein, and three patients had 
extended below-knee thrombi nto the tibioperoneal veins with calf perforators. At the 
time of the follow-up examination all 30 patients were being treated without anticoagu- 
lation. 
Conclusions: Proximal saphenous vein thrombosis should be treated with anticoaglxlation 
or at least followed by serial duplex ultrasound evaluation so that definitive therapy may 
be initiated, if progression is noted. More distal superficial venous thrombosis should be 
carefiflly followed clinically and repeat duplex ultrasound scans performed, if progression 
is noted or patient symptoms worsen. (J Vasc Surg 1996;24:745-9.) 
Traditionally, superficial thrombophlebitis has 
been considered a benign disease usually associated 
with lower extremity varicosities and a condition that 
can be managed effectively by conservative measures 
of compression, ambulation, and nonsteroidal ntiin- 
flammatory agents. 1-3 When deep vein thrombosis 
(DVT) is found in conjunction with superficial venous 
thrombosis, a relatively frequent finding, anticoagu- 
lation has been recommended. Because of  the recog- 
nized potential for embolization, surgical manage- 
ment with high saphcnous ligation with or without 
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saphenous vein stripping has been the recommended 
treatment when the saphenofemoral junction is in- 
volved. 4-7 Little is known, however, regarding the 
natural history of more distal isolated superficial 
venous thrombosis when there is no deep venous 
involvement. The development ofduplex ultrasonog- 
raphy as the noninvasive technique of choice for 
evaluation of  the lower extremity veins has made it 
possible to perform serial studies on these patients and 
to determine the time course of the disease. This study 
retrospectively reviews the vascular laboratory results 
and associated clinical findings in a series of 30 
patients who had isolated superficial venous throm- 
bosis with documented progression to DVT. 
PAT IENTS AND METHODS 
We reviewed the records of 263 patients who were 
referred to the vascular laboratory between January 
1992 and January 1996 for lower extremity venous 
duplex ultrasound examinations and were found to 
745 
JOURNAL OF VASCULAR SURGERY 
746 Chengdis et al. November 1996 
have superficial venous thrombosis but no evidence of 
any deep venous involvement. None of these patients 
had DVT only or combined deep and superficial 
venous thrombosis. Data taken from the vascular 
laboratory record included patient age, sex, inpatient 
or outpatient status at the time of presentation, 
indications for the duplex ultrasound scan, risk factors 
for thrombosis, and physical findings of the presence 
or absence of erythema, tenderness, a palpable cord, 
or varicose veins. 
A standard uplex ultrasound examination proto- 
col was followed for each patient. If the patient had 
unilateral symptoms, only that limb was evaluated; the 
asymptomatic contralateral extremity was not rou- 
tinely studied. All patients with bilateral symptoms or 
with the clinical suspicion of pulmonary embolism 
had bilateral studies. The duplex ultrasound exami- 
nation was done with the patient lying supine with his 
or her head elevated from 15 to 30 degrees and with 
5 to 10 degrees of reverse Trendelenberg tilt of the 
examination table. The leg to be examined was 
externally rotated at the hip with the knee slightly 
flexed; if necessary, the knee was supported by a small 
pillow to relive any muscle tension or guarding. 
Transverse and longitudinal imaging were both 
done with a 5 MHz linear array (Diasonics Ultra- 
sound, Santa Clara, Calif.). The deep venous ystem 
was evaluated first, from the external i iac vein above 
the inguinal ligament to the adductor hiatus; particu- 
lar attention was payed to the saphenofemoral junc- 
tion and to the confluence of the superficial femoral 
and profunda femoral veins. A transverse scanning 
plane was used; we paused every 1 to 2 cm to apply 
downward probe pressure to compress the venous 
structures and coapt the opposing vein walls. The 
greater saphenous vein was then evaluated from the 
saphenofemoral junction to the knee with a transverse 
scanning plane and similar probe compression ma- 
neuvers. After the upper leg was evaluated, transverse 
scanning and probe compression were used to exam- 
ine the popliteal vein from a posterior approach and 
the posterior tibial, peroneal, and intramuscular calf 
veins from a posteromedial pproach. The distal 
greater saphenous vein was then evaluated from the 
medial malleolus to the knee. In addition, an image of 
the lesser saphenous vein was obtained, if there were 
any symptoms or physical findings along the posterior 
calf. Finally, duplex ultrasound evaluation was done of 
any varicose veins identified as abnormally dilated 
tortuous tributaries to the greater or lesser saphenous 
veins. 
Longitudinal views were used to confirm the 
presence of any intraluminal echoes een on transverse 
scanning and to obtain color Doppler images and 
pulse Doppler spectral waveforms of venous flow 
hemodynamics n the common femoral vein above the 
saphenofemoral junction, the femoral vein at mid- 
thigh, the popliteal vein near its midpoint, and the 
greater saphenous vein at the saphenofemoral junc- 
tion, mid-thigh, and mid-calf. 
A positive examination result was based on the 
presence of echogenic material within the lumen of 
the vein and an inability to compress the vein com- 
pletely. An alteration or absence of normal venous 
Doppler flow signals from the vein segment in ques- 
tion was used to confirm the presence of obstructive 
disease. The same criteria were applied for the diag- 
nosis of DVT and superficial venous thrombosis and 
have a sensitivity and specificity greater than 95% in 
our vascular laboratory. Patients eligible for this study 
had to have thrombus i olated to the superficial veins 
with no evidence of deep venous involvement. The 
extent of the superficial venous thrombosis was re- 
corded by its most proximal point ofinvolvcmcnt: the 
saphenofemoral junction, the greater saphenous vein 
above the knee, the greater saphenous or lesser 
saphenous veins below the knee, or limited to vari- 
cosities. Follow-up examinations were done because 
of changes in patient symptoms, a change in the 
physical findings of the extent of the thrombophlebi- 
tis, or as part of a surveillance protocol to determine 
any disease progression i  patients with above-knee 
involvement who did not receive anticoagulation. 
Follow-up duplex ultrasound studies were compared 
with the original examination and evaluated for dis- 
ease progression into any of the deep veins of the 
lower extremity. 
RESULTS 
Between January 1992 and January 1996, 9286 
lower extremity venous duplex ultrasound examina- 
tions were performed in the vascular laboratory to 
rule out thrombosis. A total of 1489 (16%) examina- 
tions were positive for acute DVT, with 287 (19%) of 
these also noted to have superficial venous involve- 
ment. Isolated superficial venous thrombosis without 
any evidence of deep venous involvement was found 
in 263 (2.5%) patients; 159 (60%) were outpatients, 
and 104 were inpatients. The most proximal site of 
involvement was the saphenofemoral junction in 58 
patients (36 inpatients, 62%), the above-knee greater 
saphenous vein in 67, and below-lmee greater/lesser 
saphenous or varicose veins in 138. 
Progression to DVT was documented in 30 
(11.4%) patients at a mean time between the initial 
and follow-up examination of6.3 days (range 2 to 10 
JOURNAL OF VASCULAR SURGERY 
Volume 24, Number 5 Chengelis et al. 747 
Table I. Progression of superficial venous thrombosis to DVT 
Superficial thrombosis Progression t  DVT Femoropopliteal involvement 
Saphenofemoral junction 58 patients 8 patients 8 patients 
Proximal greater saphenous 67 patients 16 patients 16 patients 
Distal saphenous/varices 138 patients 6 patients 3 patients 
days) (Table I). In 21 patients progression was from 
the above-knee greater saphenous vein or saphe- 
nofemoral junction into the common femoral vein, 
and 18 of these thrombi were nonocclusive and did 
not cause any significant flow disturbances. Twelve of 
the 18 had a free-floating component to the thrombus 
in the common femoral venous segment. Three 
patients progressed from the above-knee greater 
saphenous vein through thigh-perforating veins to 
totally occlude the femoral vein in the thigh near the 
adductor hiatus. Three patients progressed from 
below-knee saphenous involvement into the popliteal 
vein with only one complete occlusion. Three patients 
had tibioperoneal thrombus in the calf with progres- 
sion by way of perforating veins off the below-knee 
greater saphenous system. 
Eleven men and 19 women with a mean age of 
63 + 15 years (range 26 to 90 years) were studied. 
At the time the disease progression was identified, 
18 of these patients were outpatients and 12 
inpatients; none of the 30 patients had been treated 
with anticoagulation after the initial study was per- 
formed. Associated risk factors included the 
following: active malignancy in nine patients, two of 
whom were identified after the diagnosis of DVT was 
made, recent surgery in seven, protracted immobi- 
lization in two, and a history of superficial throm- 
bophlebitis in two. Six patients, all with progression 
into the common femoral vein, were evaluated 
to rule out a source for clinically suspected pulmo- 
nary embolism on the basis of a high-probability 
ventilation-per fusion Scan. 
Physical examination findings included streaky 
erythema to near the most proximal site of involve- 
ment in 15 patients, medial eg tenderness in 26, a 
palpable cord in 20, and varicose veins in l i .  In no 
case invoMng progression i to the common femoral 
vein was a palpable cord felt all the way to the groin. 
All six of the patients with occlusion of the common 
femoral vein or the femoral vein in the thigh had 
significant unilateral limb swelling at follow-up; none 
of the patients with nonocclusive involvement of the 
common femoral vein had this finding. The six 
patients with popliteal or tibioperoneal vein involve- 
ment all had worsening of their lower leg tenderness, 
but only one, who had complete occlusion of the 
popliteal vein, had any significant limb swelling. 
When DVT was documented, the initial treatment 
for 29 patients was anticoagulafion. Eventually two of 
these patients had surgical ligation of the saphe- 
nofemoral junction, one patient with recent surgery 
because of bleeding and the second in conjunction 
with vein stripping for severe varicosities. One patient 
was given aspirin therapy after the disease progressed 
from the distal greater saphenous vein into the distal 
segment of one of the posterior tibial veins. Once 
therapy was initiated, no patient had any further 
symptoms of pulmonary embolism, and the episode 
of bleeding (which did not require transfusion) was 
the only complication of anticoagulation. 
Follow-up more than 1 month after the develop- 
ment of DVT was available for 10 patients. Nine of 
these had evidence of some degree of resolution of 
thrombus, three with complete resolution of all 
obstructive disease and six with recanalization of the 
saphenous and deep veins with residual thrombus. 
One patient with initial progression from the above- 
knee saphenous vein into the common femoral vein 
went on to have a complete femoropopliteal throm- 
bosis. This patient had had a colon cancer identified 
after the initial finding of progression to DVT. 
DISCUSSION 
The physical diagnosis of superficial throm- 
bophlebifis i based on the presence oferythematous 
streaking in the distribution of the superficial veins 
and tenderness, with thrombosis identified by a pal- 
pable cord. Although these findings can generally be 
used to establish the diagnosis, they are not reliable in 
determining the proximal extent of disease particu- 
larly in the upper thigh, where the thrombus usually 
extends beyond the area of clinical involvement. 6,s-1° 
Duplex ultrasonography as been shown to be a 
reliable technique for the evaluation of superficial 
venous thrombosis (just as it is for DVT) that provides 
objective evidence of the presence of thrombotic 
obstruction and a clear definition of its proximal 
extent. ~°-13 Because it is a noninvasive technique, it
can also be used routinely for serial evaluation to 
document any disease progression or resolution. In 
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our series duplex ultrasound follow-up was done 
between 2 and 10 days after the initial examination 
(mean 6.3 days) in patients who did not receive 
anticoagulation either because of a change in or 
persistence of symptoms or because of the desire to 
evaluate for disease progression i untreated patients. 
Superficial thrombophlebitis has been described 
as a condition to be treated with "benign neglect." It 
is frequently associated with DVT, which may be 
clinically silent. 1416 Three recent series in which 
duplex ultrasonography was used for diagnosis 
showed a20% to 40% prevalence of concurrent DVT 
in patients with superficial venous thrombosis, ll,16,1z 
similar to the findings in this study in which 19% of 
patients were noted to have concurrent deep and 
superficial disease. The occurrence of contiguous 
deep and superficial thrombosis varied from 7% to 
25%, and it was not possible to determine in most 
cases whether the progression was from the superficial 
to the deep venous ystem or vice versa, also consis- 
tent with our findings. 
Less is known regarding the natural history of 
isolated superficial venous thrombosis without con- 
current DVT, although it too can cause pulmonary 
embolism. 4'6,z Lutter et al. H stated that the perforat- 
ing veins in the lower leg were the most common 
source for deep venous extension. Lohr et al.,9 how- 
ever, showed nonocclusive xtension of thrombus 
into the common femoral vein in 21 (51%) of 41 
patients in whom ligation was done for saphenofemo- 
ral junction thrombosis. Pulliam et al) ° noted the 
saphenofemoral junction was the site of involvement 
in four of six patients with progressive superficial 
venous thrombosis extending into the deep venous 
system. 
The data from this series show the greatest inci- 
dence of progression to DVT from untreated super- 
ficial venous thrombosis in the proximal greater 
saphenous vein or saphenofemoral junction to involve 
the femoral vein, primarily by extension through the 
saphenofemoral junction. All six patients with initial 
involvement of the saphenofemoral junction who did 
not receive anticoagulation had DVT involving the 
common femoral vein. An additional 18 (27%) of 67 
patients with proximal greater saphenous disease as 
their initial finding progressed to femoropopliteal 
involvement. Only 20% of the patients in this series 
who progressed to DVT did so from lower leg 
superficial thrombophlebitis, and three of these pa- 
tients had involvement of the popliteal vein. Twenty- 
seven (90%) of the 30 patients with progression to 
DVT had progression i to the femoropopliteal sys- 
tem, placing them at increased risk for significant 
pulmonary embolism. Only three (10%) patients 
progressed to DVT by way of the lower leg perforat- 
ing veins into the tibioperoneal system. 
With little data regarding the natural history of 
superficial venous thrombosis, it is not surprising that 
its management remains controversial. The data from 
this series uggest that conservative therapy of ambu- 
lation, compression, heat, and, if needed, nonsteroi- 
dal antiinflammatory agents remains effective therapy 
for most cases of below-knee disease or that involving 
varicosities alone. This treatment does not appear to 
be adequate for more proximal greater saphenous 
vein thrombosis. Ambulation did not prevent disease 
progression, because 18 (60%) of the 30 patients were 
outpatients and fully ambulatory; this is the same 
percentage of outpatients as in the entire group with 
isolated superficial venous thrombosis. Conversely, 
immobilization did not adversely contribute to dis- 
ease progression, because only two of the inpatients 
were considered nonambulatory. 
Alternative treatments for proximal or progressive 
disease include anticoagulation or surgical igation, 
and there are data to support both. Anticoagulation 
has been shown to be effective in the prevention of 
subsequent pulmonary embolism and to cause mini- 
mal morbidity, although short-term progression of 
saphenofemoral junction thrombus into the common 
femoral vein while anticoagulation is being adminis- 
tered has been shown in up to 10% of patients. 17 
Twenty-nine of the 30 patients in this series were 
initially treated with heparin, and one, who had 
short-segment posterior tibial vein thrombus, was 
treated with aspirin. No evidence of any pulmonary 
embolism was found during the follow-up period. 
One patient who had bleeding after undergoing 
abdominal surgery had anticoagulation discontinued 
and the saphenofemoral junction ligated. One pa- 
tient, noted previously, went on to have complete 
femoropopliteal venous occlusion, but no other pa- 
tients had any evidence of further disease progression. 
The direct costs ofanticoagulafion were not evaluated 
for this patient group, but it is estimated that the 
required hospitalization and postdischarge medica- 
tion and monitoring cost approximately $8,000 to 
$10,000, similar to other reports in the literature. 9 
Although the immediate goal of anticoagulation is 
prevention of disease progression, a potential long- 
term benefit compared with surgery is preservation of
the greater saphenous vein, if it is needed for future 
arterial bypass. Three of 10 patients in this series 
evaluated more than I month after the development 
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of DVT had complete venous recanalization with no 
evidence of any residual obstructive disease or chronic 
venous insufficiency; the greater saphenous and femo- 
ral veins including those valve sites that were seen 
appeared anatomically normal by duplex ultrasound 
imaging and had normal venous flow hemodynamics. 
The remaining seven patients, however, had only 
partial recanalization (six) or extension of DVT (one), 
and significantly longer follow-up will be needed to 
determine whether the saphenous vein can be pre- 
served either anatomically or functionally in this 
setting. 
Advocates of surgical management for proximal 
superficial venous thrombosis show short-term re- 
suits equally effective as anticoagulation. High saphe- 
nous vein ligation with thrombectomy and vein 
stripping as needed is a relatively minor procedure 
performed with minimal complications. Early reports 
of surgical management have reported rates of post- 
operative pulmonary embolism between 2% and 6%, 
but these series did not objectively document the 
presence or absence of concurrent DVT.  6'18 In a more 
recent series by Lohr et al.9 involving patients with 
saphenofemoral junction thrombosis, 46% of the 
procedures were done on an outpatient basis, and 
only 10% of patients had a hospital stay of greater than 
3 days, all but one because of unrelated illnesses. One 
patient had a cardiac arrhythmia requiring extended 
hospitalization. Fifty-four percent of the procedures 
were done with the patients under local anesthetic. 
Two patients had DVT in the contralateral extremity, 
one in conjunction with saphenous vein thrombosis at 
1 week after surgery and one with a probable pulmo- 
nary embolism based on a high-probability ventila- 
tion-perfusion lung scan at 3 weeks after surgery. 
Compared with patients treated with anticoagulation, 
the surgically treated patients had a less than one third 
shorter hospital stay, and the average cost per patient 
was approximately half that of patients treated with 
anticoagulation. 
The patients in our series were initially treated 
uniformly by their primary care physicians with anti- 
coagulation. Only two patients were seen by a sur- 
geon and then only after anticoagulation had been 
started. To change these patterns will require signifi- 
cant education from the surgical community to elu- 
cidate the risks and prognosis of proximal greater 
saphenous thrombosis and the different management 
options available for effective treatment. 
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